It is also pivotal to employ novel transcriptomic techniques to explore ferroptosis-related pathways at a molecular level with inclusions and without inclusions, to understand the role of aS/tau in driving ferroptosis changes at the genome level, and to bridge the knowledge gaps in the function of specific markers in order to deepen our understanding of parkinsonism pathophysiology. This evidence concerns the gene MAPT and Parkinsonism.